Brazil Artificial Intelligence (AI) in Medical Imaging Market Report 2022 to 2030

Brazil Artificial Intelligence (AI) in Medical Imaging Market Analysis

$ 3999

Brazil artificial intelligence (AI) in medical Imaging market size was valued at $38 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $449 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the Brazil Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market inclue, Vitta (BRA), Hi Technologies (BRA), Brain4care (BRA), TissueLabs (BRA), Ninsaúde (BRA), Docway (BRA), Medcloud (BRA), Fiplex, Epistemic, BoaConsulta, GE Healthcare, Philips Healthcare, Siemens Healthineers,, IBM Watson Health, NVIDIA Corporation, and others.

ID: IN10BRDH023 CATEGORY: Digital Health GEOGRAPHY: Brazil AUTHOR: Chandani Patel

Buy Now

Brazil Artificial Intelligence (AI) in Medical Imaging

Market Executive Summary

Brazil artificial intelligence (AI) in medical Imaging market size was valued at $38 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $449. According to data from the World Bank, Brazil's total health expenditure as a percentage of GDP was 8.1%. This is lower than the average for high-income countries, which was 10.6%. The Brazilian government is the largest contributor to health expenditure, followed by households and private insurance companies. There has been a focus on increasing investment in the healthcare sector in recent years, particularly in areas such as primary healthcare and medical technology.

The increasing demand for AI-based medical imaging solutions, the growing prevalence of chronic diseases, and the government's initiatives to promote the adoption of digital technologies in healthcare are some of the key drivers of the market in Brazil. Additionally, the rise of private investments and partnerships between local companies and MNCs in the field of AI in medical imaging is expected to further boost the market growth in the country.

AI is being used in radiology to assist with image interpretation, diagnosis, and treatment planning. It is being used to identify abnormalities, lesions, and tumors in X-rays, CT scans, MRI, and ultrasound images. It also analyze cardiac images and help with diagnosis of heart conditions. It can assist in identifying anomalies, assessing heart function, and detecting heart disease.

Moreover, in oncology to assist with cancer diagnosis and treatment planning. It can help in detecting tumors, analyzing images to determine the stage and severity of cancer, and identifying treatment options AI is being used. Additionally, neurology diagnosis and treatment of neurological conditions is also being done by AI technology in various parts of Brazil. It can help in analyzing brain images to identify tumors, aneurysms, and other abnormalities, and in predicting patient outcomes. The demand for AI in Medical Imaging is increasing across Brazil, as healthcare providers seek to improve the accuracy and efficiency of diagnosis and treatment planning. Hence, Brazil AI in medical imaging market will grow in coming years.

The influx of big data, the availability of investment for AI-based startups, the development in cross-industry alliances and collaborations, and expanding government measures to promote the use of AI-based technologies are all contributing to the rapid growth of AI in medical diagnostics. It is projected that issues like a lack of knowledgeable AI employees, hazy rules, and a reluctance among medical experts to adopt these solutions will hinder market progress.

brazil AI in medical devices market

Market Dynamics

Market Growth Drivers

Technological advancements: Brazil is rapidly advancing in terms of technology, which is also driving the adoption of AI in medical imaging. There is a growing trend of digitalization in healthcare, which is creating a need for AI-powered solutions to manage and analyze large amounts of medical data.
Increasing prevalence of chronic diseases: Chronic diseases such as cancer, diabetes, and cardiovascular diseases are becoming increasingly prevalent in Brazil. AI-powered medical imaging solutions can help detect and diagnose these diseases at an early stage, leading to better treatment outcomes.
Government initiatives: The Brazilian government has launched several initiatives to promote the adoption of AI in healthcare, including the creation of a national network of AI research centers.

Market restraints:

Limited access to healthcare: While the demand for quality healthcare is growing in Brazil, access to healthcare services is still limited for many people, especially those living in rural areas. This can limit the adoption of AI-powered medical imaging solutions.
Cost concerns: AI-powered medical imaging solutions can be expensive, which can be a barrier to adoption for many healthcare providers in Brazil.
Limited infrastructure: There is a lack of infrastructure for AI-powered medical imaging in many parts of Brazil. This can limit the adoption of these solutions in some regions.
Regulatory challenges: There are still some regulatory challenges that need to be addressed to facilitate the adoption of AI-powered medical imaging solutions in Brazil, such as data privacy and security concerns.

Competitive Landscape

Key Players

Vitta (BRA)
Hi Technologies (BRA)
Brain4care (BRA)
TissueLabs (BRA)
Ninsaúde (BRA)
Docway (BRA)
Medcloud (BRA)
Fiplex
Epistemic
BoaConsulta
GE Healthcare
Philips Healthcare
Siemens Healthineers,
IBM Watson Health
NVIDIA Corporation

Recent Developments

2021: (CNPq) announced funding for a research project focused on developing AI algorithms for medical imaging analysis. The project will involve collaboration between researchers from several Brazilian universities and aims to improve the accuracy and efficiency of medical imaging diagnosis.

2021: A Brazilian start-up called Navega Therapeutics announced that it had developed an AI-based platform for analyzing brain scans to aid in the diagnosis of Alzheimer's disease. The platform uses advanced machine learning algorithms to identify patterns and markers in brain scans that are indicative of Alzheimer's disease, with the aim of improving early diagnosis and treatment.

2022: the Brazilian Health Ministry announced plans to invest in AI-based medical imaging technologies as part of a wider push to improve the country's healthcare system. The ministry stated that the use of AI in medical imaging could help to improve the accuracy and speed of diagnoses, as well as reduce costs and improve patient outcomes.

Healthcare Policies and Regulatory Landscape

In 2019, the Brazilian government created a National Artificial Intelligence Strategy with the objective of promoting the use of AI in different sectors and defining guidelines for its development in the country. This strategy is expected to have an impact on the use of AI in medical imaging as well.

In addition, the Brazilian National Health Surveillance Agency (ANVISA) has been working on the regulation of medical devices that use AI technology. In 2021, ANVISA published a public consultation document proposing guidelines for the regulation of medical devices that use AI. These guidelines include requirements for data quality, transparency, and safety, among others.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Artificial Intelligence (AI) in Medical Imaging Market Segmentation

By AI Technology

Deep Learning
Natural Language Processing (NLP)
Others

By Solution

Software Tools/ Platform
Services
- Integration
- Deployment

By Modality

When compared to CT scans, magnetic resonance imaging can produce pictures that are free of imperfections. Due to its efficiency in obtaining details and better-quality pictures of soft tissues, the MRI is frequently seen as a superior alternative to X-rays. Utilizing optical coherence tomography, three-dimensional interactions between the retina and membranes are made possible in order to control the vitreoretinal disease.

CT Scan
MRI
X-rays
Ultrasound Imaging
Nuclear Imaging

By Application

The market is dominated by the digital pathology segment, which can be linked to pathologists' rising productivity. A validation tool for image analytics is provided by digital pathology, helping pathologists process more slides in less time. This facilitates early illness identification and quicker therapy initiation. AI and digital pathology also assist doctors in making patient-centered decisions. The oncology market is also expected to grow in popularity as more individuals become aware of cancer and its increased incidence in the public. Personalized therapy is made possible by artificial intelligence algorithms that identify and comprehend the nature of malignancies. The second section focUses on AI-driven diagnostic imaging for the heart, brain, breast, and mouth.

Digital Pathology
Oncology
Cardiovascular
Neurology
Lung (Respiratory System)
Breast (Mammography)
Liver (GI)
Oral Diagnostics
Other

By End Use

The market is dominated by the healthcare sector. This is becaUse hospitals are widely dispersed and accessible; hence, many patients like hospitals. The market for medical imaging AI is also anticipated to benefit from favorable reimbursement regulations. During the anticipated time, diagnostic centers are anticipated to grow in popularity. This may be attributable to elements including rising patient awareness and a desire for diagnostic procedures and tests, all of which are fueling the market's expansion. Due to its ease in providing high-quality medical facilities in remote places, particularly rural ones, the ambulatory category is expected to develop at a quicker CAGR throughout the projection period. The availability of qualified surgeons and a surplAustralia of the necessary equipment are contributing to the expansion of the hospital market. Government assistance in emerging nations is likely to boost hospital infrastructure and technologies throughout the forecast period, which is anticipated to caUse the hospital segment to see growth.

Hospital and Healthcare Providers
Patients
Pharmaceuticals and Biotechnology Companies
Healthcare Payers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.